Movatterモバイル変換


[0]ホーム

URL:


CN101485683A - Low-sodium peritoneal dialysis liquid - Google Patents

Low-sodium peritoneal dialysis liquid
Download PDF

Info

Publication number
CN101485683A
CN101485683ACNA2009100583841ACN200910058384ACN101485683ACN 101485683 ACN101485683 ACN 101485683ACN A2009100583841 ACNA2009100583841 ACN A2009100583841ACN 200910058384 ACN200910058384 ACN 200910058384ACN 101485683 ACN101485683 ACN 101485683A
Authority
CN
China
Prior art keywords
sodium
peritoneal dialysis
low
mmol
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009100583841A
Other languages
Chinese (zh)
Inventor
欧苏
崔盛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGSHAN LIKANG PHARMACEUTICAL INDUSTRY Co Ltd CHENGDU
Original Assignee
QINGSHAN LIKANG PHARMACEUTICAL INDUSTRY Co Ltd CHENGDU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGSHAN LIKANG PHARMACEUTICAL INDUSTRY Co Ltd CHENGDUfiledCriticalQINGSHAN LIKANG PHARMACEUTICAL INDUSTRY Co Ltd CHENGDU
Priority to CNA2009100583841ApriorityCriticalpatent/CN101485683A/en
Publication of CN101485683ApublicationCriticalpatent/CN101485683A/en
Pendinglegal-statusCriticalCurrent

Links

Landscapes

Abstract

The invention discloses a low-sodium peritoneal dialysis solution. The solution does not contain bicarbonate ions, and components of the solution calculated as mmol/L comprise the following: 124 to 128 mmol/L of sodium ions, 1 to 2 mmol/L of calcium ions, 0.2 to 0.8 mmol/L of magnesium ions, 90 to 110 mmol/L of chloride ions, 37 to 47 mmol/L of lactate ions, and a corresponding isotonic agent. The low-sodium peritoneal dialysis solution, during the preparation, overcomes the defect that a special membrane material must be used in order to solve the stability problem of producing pH by decomposing bicarbonate radicals, reduces the cost, and is favorable for further expansion and popularization of clinical application.

Description

Low-sodium peritoneal dialysis liquid
Technical field
What the present invention relates to is a kind of peritoneal dialysis solution for the medical low sodium content that uses.
Background technology
Peritoneal dialysis be the kidney replacement therapy important way it, the application proportion at present clinical is increasing, for vast nephrotic has alleviated burden and misery, has improved quality of life.But the big quantity research of clinical practice shows gradually, water sodium is removed and is reduced, increase of patients undergoing peritoneal dialysis volume overload and water salt are too much, it is the hypertensive main cause of peritoneal dialysis patient, the cardiovascular complication that thereupon brings, oneself becomes the peritoneal dialysis long-term treatment and withdraws from a high common cause of rate height and cardiovascular event incidence rate and mortality rate.Everybody more and more recognizes the importance of keeping good capacity condition of patient and the control of water salt.Wherein, the peritoneal dialysis liquid product Na ion concentration that is used for the patient is too high, causes sodium ion clearance rate reduction in the body, then is the major reason that can not ignore." Chinese blood purification " 2005,4 (3); Report the exploration that this is carried out in the documents such as 2007,6 (11), but do not drawn clear conclusions.
A cardinal principle of peritoneal dialysis is that the Na ion concentration in the dialysis solution should be lower approximately than the Na ion concentration in the blood plasma, to help the removing of sodium ion.So in order to improve the clinical safety and the hommization of treatment, seek a kind of peritoneal dialysis solution of low sodium, seem very necessary.Na ion concentration in the blood of human body is about 130~140mmol/L.This product Na ion concentration of present domestic ministry standard is 141mmol/L, and the Na ion concentration of the commercially available import peritoneal dialysis liquid product that uses is 132mmol/L.
At the problems referred to above, in publication number is the Chinese patent literature of CN1953754, the low-sodium peritoneal dialysis liquid that a kind of sodium ions content is 121~129mmol/l had been proposed once.But it also simultaneously must contain hydrion and bicarbonate ion on the one hand, its liquid by two kinds of independent packaged forms is formed on the other hand, can only adopt when clinical practice two kinds of packing liquids mixing backs are used, otherwise both do not met clinical requirement, and can form precipitation yet because of the reaction of relevant ions to ion concentration.The peritoneal dialysis solution of this low sodium that contains bicarbonate ion in the preparation, can not use common film material and the special film material of essential use, to solve the stability problem that bicarbonate radical decomposes the pH that produces, therefore increased the difficulty of preparation, increase cost, influenced the further expansion and the popularization of clinical application range.
Summary of the invention
At above-mentioned situation, the present invention will provide a kind of peritoneal dialysis solution of low sodium content of not bicarbonate ion-containing.
As above-mentioned, the maximum characteristics of low-sodium peritoneal dialysis liquid of the present invention are not contain bicarbonate ion in the solution, and it consists of:
Sodium ion 124~128mmol/L,
Calcium ion 1~2mmol/L,
Magnesium ion 0.2~0.8mmol/L,
Chloride ion 90~110mmol/L,
Lactate ion 37~47mmol/L,
Isotonic agent is an amount of.
Wherein, the Na ion concentration in the above-mentioned low-sodium peritoneal dialysis liquid is preferably 125~126mmol/L.
Said isotonic agent is at least a in glucose, mannitol, aminoacid, dextran, hetastarch or the glucose polymer in the low-sodium peritoneal dialysis liquid of the present invention, wherein preferably glucose and/or glucose polymer.According to the selection of using needs and/or different isotonic agents, its consumption generally is controlled in conventional 320~400 (mmol/L) scope with the osmotic pressure with solution and gets final product.
After the low sodium abdomen of the above-mentioned form of the present invention is touched the usual manner production of dialysis solution by present like product, owing to wherein do not contain bicarbonate ion, may be packaged in the container for using, safe ready not only, reduced pollution, and overcome fully for solving bicarbonate radical and decompose the difficult problem that the stability problem that produces pH must use special membrane material in the preparation, reduced cost, help the further expansion of clinical practice and popularize.
The specific embodiment by the following examples is described in further detail foregoing of the present invention again.But this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example.Do not breaking away under the above-mentioned technological thought situation of the present invention, various replacements or change according to ordinary skill knowledge and customary means are made all should comprise within the scope of the invention.
The specific embodiment
Embodiment 1
In preparing tank, drop into glucose 15g, sodium chloride 5.05g, calcium chloride 0.26g, magnesium chloride 0.051g, sodium lactate 4.48g, after the stirring and dissolving, add active carbon 1g, boil absorption after about 10 minutes, filter decarburization, cooling, regulate pH value to 4.5~7.0, after-teeming is penetrated water to full dose (1000ml, as follows), fill in dialyzate bag, 115 ℃, the 30 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
Embodiment 2
In preparing tank, drop into mannitol 12.5g, sodium chloride 5.10g, calcium chloride 0.26g, magnesium chloride 0.071g, sodium lactate 4.48g, after the stirring and dissolving, add active carbon 1.5g, boil absorption after about 10 minutes, filter decarburization, cooling, regulate pH value to 4.5~7.0, after-teeming is penetrated water to full dose, fill in dialyzate bag, 121 ℃, the 12 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
Embodiment 3
In preparing tank, drop into sodium chloride 4.95g, calcium chloride 0.26g, magnesium chloride 0.15g, sodium lactate 5.00g, after the stirring and dissolving, add active carbon 1.0g, boil absorption after about 15 minutes, filter decarburization, cool off standby; Add the aminoacid 3.8g of amount of preparation in another preparing tank, nitrogen filled protection keeps little and boiled 15 minutes; filter, mixed electrolyte liquid is regulated pH value to 4.5~7.0; after-teeming is penetrated water to full dose, fill in dialyzate bag, 121 ℃, the 12 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
Embodiment 4
In preparing tank, drop into sodium chloride 5.10g, calcium chloride 0.26g, magnesium chloride 0.15g, sodium lactate 4.48g, after the stirring and dissolving, add active carbon 1.0g, boil absorption after about 15 minutes, filter decarburization, cool off standby; The dextran 20g that in another preparing tank, adds amount of preparation, the active carbon that adds 1% (w/v), keeping little boiled 15 minutes, filter decarburization, mixed electrolyte liquid is regulated pH value to 4.5~7.0, and after-teeming is penetrated water to full dose, fill in dialyzate bag, 117 ℃, the 30 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
Embodiment 5
In preparing tank, drop into sodium chloride 5.10g, calcium chloride 0.26g, magnesium chloride 0.051g, sodium lactate 5.00g, after the stirring and dissolving, add active carbon 1.5g, boil absorption after about 15 minutes, filter decarburization, cool off standby; Hetastarch 60g (the molecular weight 20000~30000 that in another preparing tank, adds amount of preparation, substitution value 0.4~0.7), the active carbon that adds 0.1% (w/v), keep little and boiled 12 minutes, filter decarburization, mixed electrolyte liquid, regulate pH value to 4.5~7.0, after-teeming is penetrated water to full dose, fill in dialyzate bag, 117 ℃, the 30 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
Embodiment 6
In preparing tank, drop into sodium chloride 4.90g, calcium chloride 0.26g, magnesium chloride 0.15g, sodium lactate 4.48g, after the stirring and dissolving, add active carbon 1.0g, boil absorption after about 15 minutes, filter decarburization, cool off standby; The glucose polymer 75g (starch hydrolysate that in another preparing tank, adds amount of preparation, molecular weight 13000~20000, remove molecular weight less than 13000 with greater than 20000 starch products with ultrafilter membrane), add the active carbon of 0.1% (w/v), keep little and boiled 12 minutes, filter decarburization, mixed electrolyte liquid is regulated pH value to 4.5~7.0, and after-teeming is penetrated water to full dose, fill in dialyzate bag, 121 ℃, the 12 minutes sterilization low-sodium peritoneal dialysis liquids that get product.
With the contrast test that clinical use has been carried out in low-sodium peritoneal dialysis liquid of the present invention and the commercial like product of using at present, the result is as shown in table 1.
By the analysis of statistical data of table 1 as can be seen, low-sodium peritoneal dialysis liquid of the present invention obviously is better than commercially available sample in retention of sodium and water, this is extremely important for improving patient quality of life, because retention of sodium and water not only causes peritonitis easily, but also can cause the danger that uremia produces, so being one, the peritoneal dialysis solution of low sodium selects preferably.
The clinical comparison result of the test of the different peritoneal dialysis solutions of table 1
ProjectProduct of the present inventionCommercially available sample 1Commercially available sample 2
Na ion concentration126mmol/L132mmol/L141mmol/L
Patient30 examples30 examples30 examples
Time2 years2 years2 years
Produce peritonitis3 examples7 examples8 examples
Water retention2 examples8 examples5 examples
Sodium retention2 examples6 examples8 examples
Ultrafiltration volumeIdenticalIdenticalIdentical
Nephritis1 example3 examples5 examples
Hypertension0 example0 example2 examples
Uremia1 example5 examples6 examples

Claims (4)

CNA2009100583841A2009-02-202009-02-20Low-sodium peritoneal dialysis liquidPendingCN101485683A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CNA2009100583841ACN101485683A (en)2009-02-202009-02-20Low-sodium peritoneal dialysis liquid

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CNA2009100583841ACN101485683A (en)2009-02-202009-02-20Low-sodium peritoneal dialysis liquid

Publications (1)

Publication NumberPublication Date
CN101485683Atrue CN101485683A (en)2009-07-22

Family

ID=40888845

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CNA2009100583841APendingCN101485683A (en)2009-02-202009-02-20Low-sodium peritoneal dialysis liquid

Country Status (1)

CountryLink
CN (1)CN101485683A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102579484A (en)*2012-03-192012-07-18张志勇Peritoneal dialysis solution for diseases caused by seawater immersion
CN102973600A (en)*2012-12-132013-03-20天津金耀集团有限公司Peritoneal dialysis solution (lactate) (low calcium) composition
CN103316039A (en)*2012-03-232013-09-25林正义 Pharmaceutical composition for treating renal failure in pets
US10252037B2 (en)2011-02-162019-04-09Sequana Medical AgApparatus and methods for treating intracorporeal fluid accumulation
US10398824B2 (en)2004-08-182019-09-03Sequana Medical NvDialysis implant and methods of use
US10569003B2 (en)2012-02-152020-02-25Sequana Medical NvSystems and methods for fluid management
US10716922B2 (en)2016-08-262020-07-21Sequana Medical NvImplantable fluid management system having clog resistant catheters, and methods of using same
US10769244B2 (en)2016-08-262020-09-08Sequana Medical NvSystems and methods for managing and analyzing data generated by an implantable device
US10898631B2 (en)2017-05-242021-01-26Sequana Medical NvDirect sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
CN113648328A (en)*2021-08-042021-11-16西安乐析医疗科技有限公司Peritoneal dialysis solution containing hydroxyethyl starch, novel peritoneal dialysis tube and manufacturing method
EP4029507A1 (en)*2021-01-192022-07-20Iperboreal Pharma SrlPeritoneal dialysis solution for hypertensive subjects
US11559618B2 (en)2017-05-242023-01-24Sequana Medical NvFormulations and methods for direct sodium removal in patients having severe renal dysfunction

Cited By (24)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US11839712B2 (en)2004-08-182023-12-12Sequana Medical NvImplantable fluid management system for treating heart failure
US10398824B2 (en)2004-08-182019-09-03Sequana Medical NvDialysis implant and methods of use
US10252037B2 (en)2011-02-162019-04-09Sequana Medical AgApparatus and methods for treating intracorporeal fluid accumulation
US11235131B2 (en)2011-02-162022-02-01Sequana Medical NvApparatus and methods for treating intracorporeal fluid accumulation
US11793916B2 (en)2012-02-152023-10-24Sequana Medical NvSystems and methods for fluid management
US10569003B2 (en)2012-02-152020-02-25Sequana Medical NvSystems and methods for fluid management
CN102579484B (en)*2012-03-192014-06-25张志勇Peritoneal dialysis solution for diseases caused by seawater immersion
CN102579484A (en)*2012-03-192012-07-18张志勇Peritoneal dialysis solution for diseases caused by seawater immersion
CN103316039B (en)*2012-03-232015-04-08林正义 Pharmaceutical composition for treating renal failure in pets
CN103316039A (en)*2012-03-232013-09-25林正义 Pharmaceutical composition for treating renal failure in pets
CN102973600B (en)*2012-12-132014-11-26天津金耀集团有限公司Peritoneal dialysis solution (lactate) (low calcium) composition
CN102973600A (en)*2012-12-132013-03-20天津金耀集团有限公司Peritoneal dialysis solution (lactate) (low calcium) composition
US10716922B2 (en)2016-08-262020-07-21Sequana Medical NvImplantable fluid management system having clog resistant catheters, and methods of using same
US10769244B2 (en)2016-08-262020-09-08Sequana Medical NvSystems and methods for managing and analyzing data generated by an implantable device
US11854697B2 (en)2016-08-262023-12-26Sequana Medical NvSystems and methods for managing and analyzing data generated by an implantable device
US10918778B2 (en)2017-05-242021-02-16Sequana Medical NvDirect sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
US11464891B2 (en)2017-05-242022-10-11Sequana Medical NvImplantable pump for direct sodium removal therapy having on-board analyte sensor
US11559618B2 (en)2017-05-242023-01-24Sequana Medical NvFormulations and methods for direct sodium removal in patients having severe renal dysfunction
US11602583B2 (en)2017-05-242023-03-14Sequana Medical NvDirect sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
US11844890B2 (en)2017-05-242023-12-19Sequana Medical NvFormulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction
US10898631B2 (en)2017-05-242021-01-26Sequana Medical NvDirect sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
EP4029507A1 (en)*2021-01-192022-07-20Iperboreal Pharma SrlPeritoneal dialysis solution for hypertensive subjects
CN113648328B (en)*2021-08-042022-12-27西安乐析医疗科技有限公司Peritoneal dialysis solution containing hydroxyethyl starch, novel peritoneal dialysis tube and manufacturing method
CN113648328A (en)*2021-08-042021-11-16西安乐析医疗科技有限公司Peritoneal dialysis solution containing hydroxyethyl starch, novel peritoneal dialysis tube and manufacturing method

Similar Documents

PublicationPublication DateTitle
CN101485683A (en)Low-sodium peritoneal dialysis liquid
EP1131077B2 (en)Bicarbonate-based solution in two parts for peritoneal dialysis or as a substitution solution in continuous renal replacement therapy
DK2211874T3 (en)Sterilized dialysis solutions containing pyrophosphate
JP6183832B2 (en) Oxidative stress-suppressing dialysis agent and preparation method thereof
CN107550928A (en)A kind of glucose polymer peritoneal dialysis solution and its preparation technology
CN101693039B (en)Medical composition for surgery washing
CN104622896A (en)Method for preparing sodium-potassium-magnesium-calcium glucose injection
CN111484116A (en)Method for increasing content of dissolved oxygen in water
CN103393715B (en)Sodium potassium magnesium calcium and glucose injection and preparation method thereof
CN107375326A (en)One kind balance salt flushing liquor and preparation method thereof
CN110403905A (en)A kind of control method that vitamin C injection is anti-oxidation
CN101444526B (en)Pharmaceutical composition
JP2010042312A (en)Solution set for preparation of peritoneal dialysis fluid
CN104306396A (en)Hydroxyethyl starch 130 sodium lactate ringer injection and preparation method thereof
CN114868928B (en)Skin care composition with effects of soothing nerves, aiding sleep and resisting fatigue, and preparation method and application thereof
CN105769902A (en)Production process of sodium bicarbonate injection
CN114258998B (en)Hydrogen-enriched beverage and preparation method thereof
JP2008119509A (en)Solution set for preparation of peritoneal dialysis fluid
CN104721223B (en)A kind of injection pharmaceutical composition of compound electrolyte and preparation method thereof
CN109999681A (en)A kind of high hydrogen of small molecule is soaked and preparation method thereof
CN115414383A (en) Hemodialysis concentrate and preparation method thereof
CN109078019B (en)Bicarbonate dialysate packaged by double-chamber bag and preparation method thereof
CN114558120A (en)Skin repair compound liquid
JP3733583B2 (en) Bicarbonate-containing chemical solution-filled container package
CN109464458A (en)A kind of peritoneal dialysis solution (lactate) composition and preparation method thereof

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C02Deemed withdrawal of patent application after publication (patent law 2001)
WD01Invention patent application deemed withdrawn after publication

Open date:20090722


[8]ページ先頭

©2009-2025 Movatter.jp